Aspire Rejuvenation eyes UAE expansion as Dubai builds longevity hub

Aspire Rejuvenation Clinic is in talks to bring its peptide therapy model to the United Arab Emirates as Dubai creates a new government authority focused on regulated longevity and wellness. Founder Tomo Marjanovic is meeting regional partners in Dubai this month, saying the market is ready for clinics with established medical protocols. Why it matters: - Aspire Rejuvenation is positioning itself to enter a Gulf market where peptide therapy is drawing heavy interest and regulated longevity medicine is gaining government support. - Dubai’s new policy push could accelerate investment and clinic expansion in wellness, advanced healthcare, and longevity services. - Aspire is trying to differentiate itself as an established medical provider, not a trend-driven entrant. What happened: - Aspire Rejuvenation Clinic is in active discussions with partners and potential partners about bringing its clinical model to the UAE. - Founder and CEO Tomo Marjanovic has been taking meetings in Dubai this month. - The company said it intends to establish a presence in the region and will announce partnerships when agreements are finalized. - Dubai issued a law on June 10 establishing the Dubai Longevity Authority. - His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, serves as the authority’s president. The details: - Aspire’s licensed medical providers have prescribed and managed peptide therapy protocols since the company was founded in 2019. - The clinic also offers hormone optimization, medical weight loss, and regenerative care. - Aspire operates across four US locations and also serves patients through telemedicine. - The clinic says peptide therapies are prescribed only after individualized evaluation and comprehensive lab work. - Aspire was founded in 2019 in Orlando, Florida. - The company’s services include hormone replacement therapy, peptide therapy, medical weight loss, sexual health treatment, IV therapy, and regenerative therapies. - Aspire operates locations in Florida, Pennsylvania, and Texas. - Aspire follows a patient-first model with no membership fees. - Marjanovic said, “Peptide therapy comes up in almost every conversation we have here, sometimes every hour.” - Marjanovic said the clinic is “not arriving with a trend” and is “arriving with experience.” - Marjanovic said Dubai’s move shows “exactly where this market is headed.” - Marjanovic said the company wants to bring a model built around licensed providers, real protocols, and accountability. Between the lines: - Dubai’s new authority gives the wellness and longevity sector a more formal regulatory and investment framework at the same moment private clinics are looking to expand into the region. - Aspire is signaling that clinical credibility and medical oversight will be its main selling points in a crowded wellness market. - The company’s timing suggests it wants to move before the category becomes more saturated. What’s next: - Aspire plans to continue talks with regional partners and announce agreements once they are finalized. - The company is expected to build out a formal regional presence if negotiations succeed. - Dubai’s longevity initiative is likely to keep drawing more clinics, investors, and healthcare operators into the market. The bottom line: - Aspire is betting that its seven years of peptide therapy experience will help it stand out as Dubai turns longevity care into a regulated growth sector. More information: - Learn more at tomomarjanovic.com and operationoptimal.com . - Visit Aspire Rejuvenation on LinkedIn , Instagram , Facebook , and LinkedIn profile .